Skip to main content
Back to News
Owkin has launched an agentic AI infrastructure for drug discovery through partnerships with Nvidia...
Technology
1 min read

Owkin has launched an agentic AI infrastructure for drug discovery through partnerships with Nvidia...

The AMW Read

Updates the healthcare/bio player map with a new agentic infrastructure launch that integrates foundation models (Anthropic) and compute (Nvidia) into a vertical workflow.
NoveltySignificance
Healthcare & Bio · Player MapAI Agents · Definition

Owkin has launched an agentic AI infrastructure for drug discovery through partnerships with Nvidia and Anthropic. The flagship Pathology Explorer agent achieves 23.7% higher accuracy using 5x fewer parameters than legacy models. By leveraging multimodal data from 800+ hospitals, the system reduces biological research computation times from weeks to mere hours. This transition to autonomous reasoning marks a systemic shift toward biological super intelligence and automated discovery. 🧬

#AI #DrugDiscovery #Biotech #Innovation

How This Connects

Based on Healthcare & Bio · Player Map

  1. 3w agoOpenAI model outperforms doctors in ER diagnoses, achieving 67% accuracy vs 55%OpenAI
  2. 1mo agoMedipal launches Medipal AI agent platform for specialized clinic operationsMedipal
  3. 1mo agoAmbience Healthcare unveiled a multiyear AI platform roadmap that extends clinical intelligence acro...Ambience Healthcare
  4. 1mo agoSynthpop closed a $15M Series A (total funding $23M) to scale its multi‑agent AI platform that autom...Synthpop
  5. 4mo agoOwkin has launched an agentic AI infrastructure for drug discovery through partnerships with Nvidia... · THIS ARTICLE

More news from Owkin

Stay updated with the latest news and announcements from Owkin.

View all Owkin news

Discover AI Startups

Explore 2,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard